Literature DB >> 27167999

Evaluating the Impact of Antibiotic Exposures as Time-Dependent Variables on the Acquisition of Carbapenem-Resistant Acinetobacter baumannii.

L Silvia Munoz-Price1, Rossana Rosa, Jose G Castro, Panthipa Laowansiri, Rachel Latibeaudiere, Nicholas Namias, Sergey Tarima.   

Abstract

OBJECTIVES: To determine the time-dependent effect of antibiotics on the initial acquisition of carbapenem-resistant Acinetobacter baumannii.
DESIGN: Retrospective cohort study.
SETTING: Forty-bed trauma ICU in Miami, FL. PATIENTS: All consecutive patients admitted to the unit from November 1, 2010, to November 30, 2011.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Patients underwent surveillance cultures at admission to the unit and weekly thereafter. The primary outcome was the acquisition of carbapenem-resistant A. baumannii on surveillance cultures. Daily antibiotic exposures during the time of observation were used to construct time-dependent variables, including cumulative exposures (in grams and daily observed doses [defined daily doses]). Among 360 patients, 45 (12.5%) became colonized with carbapenem-resistant A. baumannii. Adjusted Cox models showed that each additional point in the Acute Physiologic and Chronic Health Evaluation score increased the hazard by 4.8% (hazard ratio, 1.048; 95% CI, 1.010-1.087; p = 0.0124) and time-dependent exposure to carbapenems quadrupled the hazard (hazard ratio, 4.087; 95% CI, 1.873-8.920; p = 0.0004) of acquiring carbapenem-resistant A. baumannii. Additionally, adjusted Cox models determined that every additional carbapenem defined daily dose increased the hazard of acquiring carbapenem-resistant A. baumannii by 5.1% (hazard ratio, 1.051; 95% CI, 1.007-1.093; p = 0.0243).
CONCLUSIONS: Carbapenem exposure quadrupled the hazards of acquiring A. baumannii even after controlling for severity of illness.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27167999     DOI: 10.1097/CCM.0000000000001848

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Acquisition of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: just a question of time?

Authors:  Ahmed Elkalioubie; Saad Nseir
Journal:  Ann Transl Med       Date:  2016-10

2.  Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.

Authors:  Natalia Blanco; Anthony D Harris; Clare Rock; J Kristie Johnson; Lisa Pineles; Robert A Bonomo; Arjun Srinivasan; Melinda M Pettigrew; Kerri A Thom
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  High Proportions of Multidrug-Resistant Acinetobacter spp. Isolates in a District in Western India: A Four-Year Antibiotic Susceptibility Study of Clinical Isolates.

Authors:  Ingvild Odsbu; Smita Khedkar; Uday Khedkar; Sandeep S Nerkar; Ashok J Tamhankar; Cecilia Stålsby Lundborg
Journal:  Int J Environ Res Public Health       Date:  2018-01-19       Impact factor: 3.390

4.  Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study.

Authors:  Norihisa Yamamoto; Shigeto Hamaguchi; Yukihiro Akeda; Pitak Santanirand; Narong Chaihongsa; Suntariya Sirichot; Suwichak Chiaranaicharoen; Hideharu Hagiya; Kouji Yamamoto; Anusak Kerdsin; Kazuhisa Okada; Hisao Yoshida; Shigeyuki Hamada; Kazunori Oishi; Kumthorn Malathum; Kazunori Tomono
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-27       Impact factor: 4.887

5.  Time series analysis of antibacterial usage and bacterial resistance in China: observations from a tertiary hospital from 2014 to 2018.

Authors:  Shuangshuang Zeng; Zhijie Xu; Xiang Wang; Wanli Liu; Long Qian; Xi Chen; Jie Wei; Minwen Zhu; Zhicheng Gong; Yuanliang Yan
Journal:  Infect Drug Resist       Date:  2019-08-28       Impact factor: 4.003

6.  Structural equation modeling the "control of gut overgrowth" in the prevention of ICU-acquired Gram-negative infection.

Authors:  James C Hurley
Journal:  Crit Care       Date:  2020-05-04       Impact factor: 9.097

7.  Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter spp. from clinical samples at Jimma medical center, Ethiopia.

Authors:  Tsegaye Sewunet; Daniel Asrat; Yimtubezinash Woldeamanuel; Abraham Aseffa; Christian G Giske
Journal:  Front Microbiol       Date:  2022-09-20       Impact factor: 6.064

8.  Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship.

Authors:  Po-Yen Huang; Shian-Sen Shie; Jung-Jr Ye; Shih-Pin Lin; Tsui-Ping Liu; Ting-Shu Wu; Tsu-Lan Wu; Shiow-Shuh Chuang; Ming-Huei Cheng; Yu-Chia Hsieh; Ching-Tai Huang
Journal:  BMC Infect Dis       Date:  2017-08-30       Impact factor: 3.090

9.  Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.

Authors:  Gennaro De Pascale; Gennaro Martucci; Luca Montini; Giovanna Panarello; Salvatore Lucio Cutuli; Daniele Di Carlo; Valentina Di Gravio; Roberta Di Stefano; Guido Capitanio; Maria Sole Vallecoccia; Piera Polidori; Teresa Spanu; Antonio Arcadipane; Massimo Antonelli
Journal:  Crit Care       Date:  2017-07-05       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.